We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IMO:TSXImperial Oil Limited Analysis

Data as of 2026-03-13 - not real-time

CA$166.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Imperial Oil is trading well above its short‑ and long‑term moving averages, with the price at C$166.32 compared to the 20‑day SMA of C$162.47 and the 200‑day SMA of C$127.36, indicating a bullish price trend. However, the MACD histogram is negative and the signal line is labeled bearish, while the RSI sits at 64, suggesting the stock may be edging toward overbought conditions and could face a short‑term pullback. Volatility is elevated at over 33% on a 30‑day basis, and the beta below 1 points to lower systematic risk but heightened idiosyncratic swings. The technical picture is therefore mixed: strong price momentum tempered by weakening momentum indicators and high price volatility.
Fundamentally, revenue has contracted by roughly 10% year‑over‑year and margins remain thin (gross margin ~17%, operating margin ~5%). The stock trades at a forward PE of 21.1, well above the industry average of 22.2 when adjusted for growth, and the DCF‑derived fair value of C$107.3 implies a downside of more than 27% from current levels. Analysts have downgraded the stock to “underperform,” and the consensus target price sits near C$120, far below the market price. Despite these concerns, the dividend yield of 2.1% is backed by a payout ratio under 45%, indicating sustainable cash flow for shareholders.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Technical bearish MACD divergence
  • Proximity to resistance at C$169.07
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustainable dividend yield
  • Continued earnings pressure from revenue decline
  • Uncertainty around oil price dynamics

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Fundamental overvaluation versus DCF fair value
  • Long‑term sector headwinds from energy transition
  • Analyst consensus of underperformance

Key Metrics & Analysis

Financial Health

Revenue Growth-10.30%
Profit Margin6.97%
P/E Ratio25.7
ROE14.29%
ROA7.11%
Debt/Equity19.02
P/B Ratio3.6
Op. Cash FlowCA$6.7B
Free Cash FlowCA$4.1B
Industry P/E22.2

Technical Analysis

TrendBullish
RSI64.4
SupportCA$154.64
ResistanceCA$169.07
MA 20CA$162.47
MA 50CA$148.12
MA 200CA$127.36
MACDBearish
VolumeStable
Fear & Greed Index72.39

Valuation

Fair ValueCA$107.31
Target PriceCA$120.88
Upside/Downside-27.32%
GradeOvervalued
TypeValue
Dividend Yield2.10%

Risk Assessment

Beta0.70
Volatility33.76%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.